ATA652178A - Verfahren zur herstellung von amidinosulfonsaeure- derivaten und von deren salzen pharmazeutische zusammensetzungen - Google Patents
Verfahren zur herstellung von amidinosulfonsaeure- derivaten und von deren salzen pharmazeutische zusammensetzungenInfo
- Publication number
- ATA652178A ATA652178A AT0652178A AT652178A ATA652178A AT A652178 A ATA652178 A AT A652178A AT 0652178 A AT0652178 A AT 0652178A AT 652178 A AT652178 A AT 652178A AT A652178 A ATA652178 A AT A652178A
- Authority
- AT
- Austria
- Prior art keywords
- producing
- pharmaceutical compositions
- acid derivatives
- amidinosulfonic acid
- salts pharmaceutical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/32—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
- C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/26—Radicals substituted by sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
- C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
- C07D285/135—Nitrogen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB3746877 | 1977-09-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
ATA652178A true ATA652178A (de) | 1981-09-15 |
AT366666B AT366666B (de) | 1982-04-26 |
Family
ID=10396713
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT0652178A AT366666B (de) | 1977-09-08 | 1978-09-08 | Verfahren zur herstellung von neuen amidinosulfon- saeurederivaten und von deren salzen |
Country Status (14)
Country | Link |
---|---|
US (3) | US4210658A (de) |
EP (1) | EP0009061A1 (de) |
JP (1) | JPS5452081A (de) |
AT (1) | AT366666B (de) |
AU (1) | AU518821B2 (de) |
CA (1) | CA1111040A (de) |
DK (1) | DK398078A (de) |
FI (1) | FI62530C (de) |
HU (1) | HU180294B (de) |
IL (1) | IL55539A (de) |
IT (1) | IT1099492B (de) |
NO (1) | NO783053L (de) |
YU (1) | YU213078A (de) |
ZA (1) | ZA785113B (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4210658A (en) * | 1977-09-08 | 1980-07-01 | Smith Kline & French Laboratories Limited | Amidinosulphonic acid derivatives |
US4375547A (en) * | 1980-10-02 | 1983-03-01 | Eli Lilly And Company | N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine |
IE53068B1 (en) * | 1981-06-15 | 1988-05-25 | Merck & Co Inc | Diamino isothiazole-1-oxides and -1,1-dioxides as gastic secretion inhibitors |
AU2222083A (en) * | 1982-12-14 | 1984-06-21 | Smith Kline & French Laboratories Limited | Pyridine derivatives |
US4656291A (en) * | 1985-03-15 | 1987-04-07 | Mcneilab, Inc. | Process for producing amidine sulfonic acids |
US4693850A (en) * | 1985-03-15 | 1987-09-15 | Mcneilab, Inc. | Methane sulfonic acid derivatives |
US4656270A (en) * | 1985-03-15 | 1987-04-07 | Mcneilab, Inc. | Process for producing guanidines such as linogliride |
US4781866A (en) * | 1985-03-15 | 1988-11-01 | Mcneilab, Inc. | Process for producing amidine sulfonic acid intermediates for guanidines |
US4962114A (en) * | 1986-01-21 | 1990-10-09 | Yale University | 1-alkyl-1-sulfonyl-2-alkoxycarbonylsulfenylhydrazines having antineoplastic activity |
US4952573A (en) * | 1988-03-23 | 1990-08-28 | Laboratoirs Alcon S.A. | Compounds having GABA like activity, and use of same in tissue irrigating solutions |
US5130441A (en) * | 1990-02-06 | 1992-07-14 | Allergan, Inc. | Method for producing amino-2-imidazoline derivatives |
US5237072A (en) * | 1990-02-06 | 1993-08-17 | Allergan, Inc. | Method for producing amino-2-imidazoline derivatives |
US20230349922A1 (en) | 2020-08-11 | 2023-11-02 | Université De Strasbourg | H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE758146A (fr) * | 1969-10-29 | 1971-04-28 | Smith Kline French Lab | Derives de l'amidine |
US3734924A (en) * | 1970-10-14 | 1973-05-22 | Smith Kline French Lab | Carboxamidines |
US4109003A (en) * | 1974-03-12 | 1978-08-22 | Smith Kline & French Laboratories Limited | Pharmacologically active compounds |
US4090026A (en) * | 1974-09-02 | 1978-05-16 | Smith Kline & French Laboratories Limited | Certain nitrogen heterocyclic isothiocyanate esters |
US4154838A (en) * | 1975-07-31 | 1979-05-15 | Smith Kline & French Laboratories Limited | Alkoxy pyridine |
GB1574214A (en) * | 1976-03-11 | 1980-09-03 | Smith Kline French Lab | Amidines |
US4210658A (en) * | 1977-09-08 | 1980-07-01 | Smith Kline & French Laboratories Limited | Amidinosulphonic acid derivatives |
-
1978
- 1978-09-06 US US05/940,063 patent/US4210658A/en not_active Expired - Lifetime
- 1978-09-07 NO NO783053A patent/NO783053L/no unknown
- 1978-09-07 HU HU78SI1647A patent/HU180294B/hu unknown
- 1978-09-07 CA CA310,844A patent/CA1111040A/en not_active Expired
- 1978-09-08 IT IT27493/78A patent/IT1099492B/it active
- 1978-09-08 FI FI782760A patent/FI62530C/fi not_active IP Right Cessation
- 1978-09-08 DK DK398078A patent/DK398078A/da not_active Application Discontinuation
- 1978-09-08 AU AU39704/78A patent/AU518821B2/en not_active Expired
- 1978-09-08 EP EP78300359A patent/EP0009061A1/de not_active Withdrawn
- 1978-09-08 YU YU02130/78A patent/YU213078A/xx unknown
- 1978-09-08 IL IL55539A patent/IL55539A/xx unknown
- 1978-09-08 ZA ZA00785113A patent/ZA785113B/xx unknown
- 1978-09-08 AT AT0652178A patent/AT366666B/de not_active IP Right Cessation
- 1978-09-08 JP JP11121478A patent/JPS5452081A/ja active Pending
-
1979
- 1979-11-05 US US06/090,949 patent/US4265896A/en not_active Expired - Lifetime
-
1980
- 1980-11-24 US US06/209,449 patent/US4375472A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ZA785113B (en) | 1979-08-29 |
US4375472A (en) | 1983-03-01 |
AT366666B (de) | 1982-04-26 |
CA1111040A (en) | 1981-10-20 |
IT7827493A0 (it) | 1978-09-08 |
AU518821B2 (en) | 1981-10-22 |
FI782760A (fi) | 1979-03-09 |
YU213078A (en) | 1983-01-21 |
FI62530B (fi) | 1982-09-30 |
EP0009061A1 (de) | 1980-04-02 |
IL55539A (en) | 1982-01-31 |
US4265896A (en) | 1981-05-05 |
AU3970478A (en) | 1980-03-13 |
IL55539A0 (en) | 1978-12-17 |
US4210658A (en) | 1980-07-01 |
JPS5452081A (en) | 1979-04-24 |
FI62530C (fi) | 1983-01-10 |
IT1099492B (it) | 1985-09-18 |
DK398078A (da) | 1979-03-09 |
NO783053L (no) | 1979-03-09 |
HU180294B (en) | 1983-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AT365576B (de) | Verfahren zur herstellung von neuen n-alkylpiperidinderivaten und deren saeureadditionssalzen | |
ATA276978A (de) | Verfahren zur herstellung von neuen guanidin- derivaten und von deren saeureadditionssalzen | |
AT358023B (de) | Verfahren zur herstellung von neuen substi- tuierten 1,1,2-triphenylalken-derivaten und von deren saeureadditionssalzen | |
ATA642178A (de) | Verfahren zur herstellung von neuen thienothiazinderivaten und von deren salzen | |
AT361937B (de) | Verfahren zur herstellung von neuen 4-acyl- aminophenyl-aethanolaminen und deren saeure- additionssalzen | |
ATA551578A (de) | Verfahren zur herstellung von neuen prostanderivaten und deren salzen | |
AT365184B (de) | Verfahren zur herstellung von neuen phthalazinderivaten und deren saeureadditionssalzen | |
ATA652178A (de) | Verfahren zur herstellung von amidinosulfonsaeure- derivaten und von deren salzen pharmazeutische zusammensetzungen | |
ATA338078A (de) | Verfahren zur herstellung von 5(6)-thiobenzimidazol-derivaten sowie von deren salzen en und deren salzen | |
AT361480B (de) | Verfahren zur herstellung von neuen amino- alkoxyphenyl-derivaten und deren physiologisch vertraeglichen saeureadditionssalzen | |
AT363474B (de) | Verfahren zur herstellung neuer carbostyrilderivate und ihrer pharmazeutisch geeigneten saeureadditionssalze | |
AT363937B (de) | Verfahren zur herstellung von neuen bispidinderivaten und deren salzen | |
AT363923B (de) | Verfahren zur herstellung von neuen 8-amino-alkyltetracyclononanen und von deren saeureadditionssalzen | |
AT360033B (de) | Verfahren zur herstellung von neuen tetrahydro- -s-triazinthionen und deren saeure- additionssalzen | |
ATA398678A (de) | Verfahren zur herstellung von neuen 4- acetamidophenyl-alpha-(2-methyl-ind(en/ol)- -3-yl)-acetaten und deren saeureadditionssalzen | |
AT358731B (de) | Verfahren zur herstellung von cyanacetamid- -derivaten und deren salzen | |
ATA614979A (de) | Verfahren zur herstellung von neuen amino- alkoxyphenyl-derivaten und deren physiologisch vertraeglichen saeureadditionssalzen | |
ATA112180A (de) | Verfahren zur herstellung von neuen guanidin- derivaten und von deren saeureadditionssalzen | |
AT369740B (de) | Verfahren zur herstellung von neuen thiodibenzthiepinen und deren saeureadditionssalzen | |
ATA356778A (de) | Verfahren zur herstellung von neuen 4-hydroxy- thiazolidin-2-thion-derivaten und von deren salzen | |
ATA395877A (de) | Verfahren zur herstellung von methylamin- derivaten und von deren saeureadditonssalzen | |
ATA250880A (de) | Verfahren zur herstellung von neuen alkanolamin- derivaten und deren saeureadditionssalzen | |
AT365585B (de) | Verfahren zur herstellung von neuen 2-methyl-2phenoxypropionsaeurederivaten und deren physiolo- gisch vertraeglichen salzen | |
AT365587B (de) | Verfahren zur herstellung von neuen 2-methyl-2phenoxypropionsaeurederivaten und deren physiolo- gisch vertraeglichen salzen | |
AT366045B (de) | Verfahren zur herstellung von neuen phthalazinderivaten und deren saeureadditionssalzen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ELJ | Ceased due to non-payment of the annual fee |